Skip to content

O-I Glass OI Cumulative Cost Basis

Cumulative Cost Basis at other companies

Trimas logo
TrimasTRS
Greif logo
GreifGEF
International Paper logo
International PaperIP
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Dow logo
DowDOW

Other financials

Income statement

See full
Revenue$1.5B-1.7%
Gross profit$199.0M-28.9%
Operating income-$53.0M-394%
Net income-$73.0M-356%
EPS (diluted)-$0.48-380%

Balance sheet

See full
Cash & equivalents$317.0M-25.2%
Total debt$5.0B-1.0%
Total equity$1.3B+19.9%
Total assets$9.0B+2.5%

Cash flow

See full
Operating cash flow-$294.0M-71.9%
CapEx$142.0M+5.2%
Free cash flow-$436.0M-42.5%

Valuation

See full
Market cap$1.47B-32.4%
Enterprise value$6.11B-9.6%
P/S0.2×-0.1×

Profitability

See full
Gross margin16.1%+0.6pp
Operating margin7.5%-5.1pp
Net margin-2.9%-0.1pp
FCF margin4.1%

Returns & leverage

See full
Return on equity-10.9%+7.0pp
Debt / equity4.1×-0.6×
Current ratio1.3×0.0×

Where this comes from

Reported directly by O-I Glass in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: O-I Glass’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about O-I Glass's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is O-I Glass's cumulative cost basis?
O-I Glass (OI) reported cumulative cost basis of $8.38B in Q4 2025.
How has O-I Glass's cumulative cost basis changed year-over-year?
O-I Glass's cumulative cost basis increased by 7.6% year-over-year, from $7.79B to $8.38B.
What is the long-term trend for O-I Glass's cumulative cost basis?
Over 5 years (2020 to 2025), O-I Glass's cumulative cost basis has grown at a 3.6% compound annual growth rate (CAGR), from $7.02B to $8.38B.